Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04205240
Title Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

multiple myeloma

Therapies

Cyclophosphamide + Daratumumab + Mycophenolate mofetil + Tacrolimus

Fludarabine + Melphalan

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.